BioInnovations EdiX Group

By 2026, "Precision Dosing" has become the standard in China’s top hospitals. Because children respond differently to growth hormone based on their genetic makeup, clinicians now use Pharmacogenomics to tailor the dosage.

Testing for specific gene variants (such as the GHR-d3 receptor) allows doctors to predict which children will be "high responders" and which may require higher doses to see results. This precision prevents "over-treatment" and helps minimize side effects, such as joint pain or glucose intolerance. By personalizing the treatment plan from the start, Chinese endocrinologists have maximized the efficacy of the medication while optimizing the cost-to-benefit ratio for families.